Time

Subject

Presenter

8:00– 10:00

8.00-8.10

Quran & National Anthem

8.10-8.30

Glorious Iran at a glance (Movie)

8.30-8.40

Welcome Note: President of the 6th congress of SIOP ASIA

H. Abolghasemi (Iran)

8.40-8.50

Welcome Note: Minister of  Health & Medical Education

8.50-9.00

Welcome Note: Chairman of Scientific Committee

P. Vossough (Iran)

9.00-9.10

Welcome Note: Director of  Kish Free Zone

A. Karimi (Iran)

9.10-9.20

Incidence of cancer in Iran (Mahak Cancer Register)

M. Faranoush (Iran)

9.20-9.30

PODC and Chromatin as a potential element of anti-leukemic treatment

G. Prindull (Germany)

9.30-9.40

Impact of PODC Activities in improving management of pediatric malignancies  in developing countries

H.P. Wagner (Switzerland)

9.40-9.50

MAHAK report

A. Ahmadian (Iran)

9.50-10.00

Peyman report

M. Hosseinkhah (Iran)

10.00-10.30

Break

Chair Persons: A. Biondi (Italy) - M.T. Arzanian(Iran) - J. Nachman(USA)

Time

Program

Time

Subject

Presenter

10:30- 13:00

ALL

10.30-11.00

ALL Treatment: current status

A. Biondi (Italy)

11.00-11.30

ALL in adolescence

K. Alimoghadam (Iran)

11.30-12.00

ALL: relapse strategy

A. Biondi (Italy)

12.00-12.30

ALL : COG Experience

J. Nachman(USA)

12.30-13.00

Cytogenetic and MRD in ALL

A. Biondi (Italy)

Lunch

Chair Persons: U. Creutzig (Germany) – A. Biondi (Italy)

Time

Program

Time

Subject

Presenter

14:00 – 15:30

AML

14.00-14.30

AML: Current treatment strategy

U. Creutzig (Germany)

14.30-15.00

Monoclonal Antibody in AML Treatment

A. Biondi (Italy)

15.00-15.30

Chemotherapy versus BMT in childhood AML

U. Creutzig  (Germany)

15:30 – 16:00

Break

Chair Persons: C.K. Li (Hong Kong) – A. Ghavamzadeh (Iran) - F. Sayad (Lebanon)

Time

Program

Time

Subject

Presenter

16:00 – 18:00

HSCT

16.00-16.30

Current Indications of BMT in pediatric malignant conditions

C. K. Li (Hong Kong)

16.30-16.50

Hematopoietic Stem Cell Transplantation in Iran

A. Ghavamzadeh (Iran)

16.50-17.15

BMT in relapse Leukemia

F. Sayad (Lebanon)

17.15-18.00

Panel Discussion

C.K. Li (Hong Kong)
A. Ghavamzadeh (Iran)
F. Sayad (Lebanon)
A.A. Hamidieh (Iran)

Program

Time

Subject

Presenter

19:00–20:50

Presidential Symposium

19.00-19.10

Quran & National Anthem

19.10-19.20

Welcome Note: President of SIOP International

R.M. Egeler (Netherland)

19.20-19.30

Asian Landscape

P. Kurkure (India)

19.30-19.40

Status of Pediatric Hematology Oncology in Iran

H. Abolghasemi (Iran)

19.40-19.50

Progress in South East Asia

Sutaryo (Indonesia)

19.50-20.00

Progress in SAARC Countries

R. Dalvi (India)

20.00-20.10

Middle East and MECCA Development

Z. Al Lamki (Bahrain)

20.10-20.20

West and Central Asia Advances

A.A. Hossein Pour Feizi (Iran)

Subject

Presenter

10:30-13:00

10:30-10:40

Effect of maternal diet before and during pregnancy in children childhood leukemia

A. Najafi (Iran)

10:40-10:50

Pursue long after cancer treatment in childhood, adolescence and young

T. Malahi (Iran)

10:50-11:00

Management and administration of pain in children with cancer

N. Gholami (Iran)

11:00-11:10

Relationship between blood group and  location of life with leukemia

P. Tatar pour (Iran)

11:10-11:20

How to improve quality of life in children with cancer: a systematic review

F. Khorashadizedeh (Iran)

11:20-11:30

Evaluation of the Association between Paternal Occupational Exposure and Children Cancers (Leukemia and Non-Hodgkin lymphoma)

A. Atefi (Iran)

11:30-11:40

Antioxidants and cancer prevention

A. Souzani (Iran)

11:40-11:50

Coping with Symptoms Dstress in Egyptian Children with Advanced Cancer

N. Elkateb (Egypt)

11:50-12:00

A survey of stress among pediatric oncology nurses

M. Soltanian (Iran)

12:00-12:10

The report of risk factors of childhood Leukemia in South Iranian

S. Senemar (Iran)

12:10-12:20

Evaluation of risk factors in children with ALL in Mashhad-Iran

H. Hashemizadeh (Iran)

12:20-12:30

Mother's Educational Needs about Etiology of Children's Leukemia

S. Sameti (Iran)

12:30-12:40

Surveying the effect of parents' education on the quality of life on children with leukemia referred to Motahari clinic, Shiraz, 2009

N. Asadi (Iran)

12:40-12:50

Quality of life measuring in children with acute lymphoblastic leukemia applied to Afzalipour Hospital, Kerman, 2009

F. Hashemi (Iran)

12:50-13:00

Free paper

13:00 – 14:00

Lunch

Subject

Presenter

14:00 – 15:30

14.00-14.30

Role of Ifosfamide in childhood cancer

O. Oberlin (France)

14.50-15.00

Non-medical treatment methods abd scales of cancer pain in children

M. Taheri (Iran)

15.00-15.15

The use of total implantable venous access device (TIVAD)

A. Mirshemirani (Iran)

15.15-15.30

Sub pectoral port implantation vs. subcutaneous port implantation in children with malignant disease

M. Rouzrokh (Iran)

15:30 – 16:00

Break

Time

Subject

Presenter

16:00 – 18:00

16.00-16.30

Late effect of  Ifosfamide

O. Oberlin (France)

16.30-16.40

Pattern and  incidence3 of childhood leukemia in Basra, 2003-2007

L. Alrudainy (Iraq)

16.40-16.50

Langerhance Cell Histiocytosis in North - Western Iran

A. A. Hossein Pour Feizi (Iran)

16.50-17.00

Free paper

17.00-17.10

Occurrence of teratomas in infants and children

H. Pourang (Iran)

17.10-17.20

Invasive Aspergillosis in Pediatric Hematology Oncology Ward

P. Badiee (Iran)

17.20-17.30

Infant leukemia: Perspective from  tertiary care pediatric hospital

P. Sharma (India)

17.30-17.40

Solid Tumors in Infancy – an Adult

S.N. Bhatnagar (India)

17.40-17.50

Malignant germ cell tumors – outcome analysis

Y. Kumar Sarin (India)

17.50-18.00

Hyaline vascular- type Castleman's disease in the Hilum of Liver: A Case Report

H. Karami (Iran)

Time

Program

Time

Subject

Presenter

8:00 – 10:15

CML

8.00-8.30

Treatment of pediatric patients with chronic myeloid leukemia by tyrosine kinas inhibitors

M. Suttorp (Germany)

8.30-8.50

Juvenile myelomoncytic Leukemia
(JMML)! What is new?

B. Agarwal (India)

8.50-9.10

Stem Cell Transplantation in CML

B. Bahar (Iran)

9.10-9.35

Treatment of Imatinb-Resistant Chronic Myeloid Leukemia in Pediatrics.

M. Suttorp (Germany)

9.35-9.50

Cytogenetic in CML

R. Kariminejad (Iran)

9.50-10.00

Imatinib Mesylate in Pediatric CML

G. Bahoush (Iran)

10.00-10.15

Panel Discussion

M. Suttorp (Germany)
B. Agarwal (India)
B. Bahar (Iran)
R. Kariminejad (Iran)

10:15 – 10.30

Break

Chair Persons: A. Claviez (Germany) - F. Madanat (Jordan) – T. Girinsky (France) -  M. Alebouyeh (Iran)

Time

Program

Time

Subject

Presenter

10:30 – 13:00

HD

10.30-10.50

Current  status in treatment Hodgkin's disease

A. Claviez (Germany)

10.50-11.10

Hodgkin Lymphoma in Jordan

F. Madanat (Jordan)

11.10-11.30

Treatment of replase in Hodgkin's disease

A. Claviez (Germany)

11.30-11.50

Role of XRT & PET scan in Hodgkin's diseases

T. Girinsky (France)

11.50-12.10

Treatment Hodgkin Disease in India

L. S. Arya (India)

12.10-12.20

Hodgkin's disease in developing countries

M. Alebouyeh (Iran)

12.20-12.30

Hodgkin Lymphoma treatment as Pediatric Oncology Group Trial

M.A. Ehsani (Iran)

12.30-13.00

Panel Discussion

A. Claviez (Germany)
F. Madanat (Jordan)
T. Girinsky (France)
M. Alebouyeh (Iran)

Lunch

Chair Persons:  W. Woessmann (Germany) –  B. Poopak (Iran)

Time

Program

Time

Subject

Presenter

14:00 – 15:30

NHL

14.00-14.30

Current treatment strategy in NHL

O. Oberlin(France)

14.30-14.50

Application of Monoclonal antibody  in treatment NHL

A. Claviez(Germany)

14.50-15.10

Current treatment strategy for relapsed or refractory Non Hodgkin's Lymphoma

W. Woessmann (Germany)

15.10-15.30

Cytogenetic and molecular biology in NHL

B. Poopak (Iran)

15:30 – 16:00

Break

Chair Persons: J. Nicholson (UK) – Sh. Ansari (Iran) – H.P. Wagner (Switzerland)

Time

Program

Time

Subject

Presenter

16:00 – 18:00

GCT

16.00-16.30

CNS germinoma

J. Nicholson (UK)

16.30-16.50

CNS non germinoma 

J. Nicholson (UK)

16.50-17.20

Pediatric  germ cell Tumors

Sh. Ansari(Iran)

17.20-17.40

Reorganization of PODC

H.P Wagner (Switzerland)

17.40-18.00

Panel Discussion

J. Nicholson (UK) 
Sh. Ansari (Iran)
H.P. Wagner(Switzerland) 

20:00 – 23:00

Gala Dinner

Subject

Presenter

8:00 – 10:00

8:00 – 8:10

Results of chemotherapy by UKCCSG protocol in children with acute lymphoblastic leukemia: Clinical characteristics and Outcome

M. Pedram (Iran)

8:10 – 8:20

Humoral immunity against hepatitis B, tetanus and diphtheria following chemotherapy for hematologic malignancies

S. Alavi

8:20 – 8:30

Evaluation of Relative Frequency of late effects of cancer treatment in Survivor of childhood cancer in Shafa Hospital from 1365-1382

B. Keikhaei (Iran)

8:30 – 8:40

Karyotype in children with Acute Lymphoblastic Leukemia

Sh. Nazari (Iran)

8:40 – 8:50

Malignancies in patients with β-thalassemia major and β-thalassemia intermedia: a multicenter study in Iran

M. Karimi (Iran)

8:50 – 9:00

Second Malignant Neoplasmas

M. Hashemieh (Iran)

9:00 – 9:10

Musculoskeletal involvement as manifestation of adrenal Neuroblastoma in a childhood

N. Mirbehbahani (Iran)

9:10 – 9:20

9:20 – 9:30

Tumor lysis in Syndrom

A.A. Hedayatiasl (Iran)

9:30 – 9:40

Clinical characteristics and the prognosis of childhood Rhabdomyosarcoma in 60 patients treated at a single institute

N. Rezaei (Iran)

9:40 – 9:50

Gonadal function and fertility in male survivors treated for Hodgkin’s disease in Iran

K. Arjmandi Rafsanjani (Iran)

9:50 – 10:00

Presentation of Burkitt’s Lymphoma in Southern Iran

M. Shahriari (Iran)

10:00 – 10:30

Break

Chair Persons: O. Oberlin (France) – M. Abboud (Lebanon) - KH. Jamshidi (Iran) – KH Zandian(Iran)

Time

Program

Time

Subject

Presenter

10:30 – 13:00

Soft tissue & Bone Sarcomas

10.30-11.00

Current treatment strategy in soft tissue sarcoma

O. Oberlin (France)

11.00-11.30

Limb salvage in sarcoma

M. Abboud (Lebanon)

11.30-11.50

Molecular targets and upcoming therapies in soft tissue sarcoma

R. Saab (Lebanon)

11.50-12.10

Soft tissue sarcoma report in Iran

A. Mehrvar (Iran)

12.10-12.30

Surgical approaches in bone sarcoma

KH. Jamshidi (Iran)

12.30-13.00

Panel Discussion

O. Oberlin (France)
M. Abboud (Lebanon)
KH. Zandian (Iran)
KH. Jamshidi (Iran)

Lunch

Time

Subject

Presenter

14:00 – 15:30

14:00 – 14:10

A five year study of children with wilms tumor who admitted in beast hospital in Hamadan during 2003-2008

H. Khoeini Poor far (Iran)

14:10 – 14:20

Effect of intrathecal chemotherapy without cranial irradiation for CNS prophylaxis in pediatric acute lymphoblastic leukemia.

H. Mahmoodi Nesheli (Iran)

14:20 – 14:30

Prevalence and survival rate of malignancies in 394 cases, Amirkola children hospital 1994-2009

A. Tamaddoni (Iran)

14:30 – 14:40

acute ischemic stroke as the first manifestation of ALL

A. Tavasoli (Iran)

14:40 – 14:50

Ciprofloxacin & Children Cancer

N. Najafi (Iran)

14:50 – 15:00

Late effects of childhood cancer treatments in Iran

N. Mehrvar (Iran)

15:00 – 15:10

Effectiveness of zinc sulfate in chemotherapy- induced hair loss & alopecia " (Preliminary report)

M.S. Rahiminejad (Iran)

15:10 – 15:20

Cystatin c is a sensitive marker to monitor renal function during chemotherapy.

M. Naderi (Iran)

15:20 – 15:30

Abdominal Masses in Neonates

R. Sari-Sorkhabi (Iran)

15:30 – 16:00

Break

Chair Persons: MT. Arzanian (Iran) - M. Minkov (Austria) – F. Berthold (Germany) – E. Hiyama (Japan) – B. Shamsian (Iran)

Time

Program

Time

Subject

Presenter

16:00 – 18:00

Neuroblastoma & LCH

16.00-16.20

Current treatment strategy in Neuroblastoma

F. Berthold (Germany)

16.20-16.40

Molecular Diagnosis in  Neuroblastoma

E.  Hiyama (Japan)

16.40-17.00

Current treatment strategy in LCH

M. Minkov (Austria)

17.00-17.10

Langerhance cell histiocytosis in a child with non-Hodgkin lymphoma

B. Shamsian (Iran)

17.10-17.30

Hemophagocytic Lymphohistiocytosis: Experience from a resource poor country

A. Naqvi (Canada)

17.30-18.00

Panel Discussion

MT. Arzanian (Iran)
M. Minkov (Austria)
E.  Hiyama (Japan)
F. Berthold (Germany)
B. Shamsian (Iran)
A. Naqvi (Canada)

Time

Program

Time

Subject

Presenter

8:00 – 10:15

Retinoblastoma  

8.00-8.30

Current treatment strategy in  Retinoblastoma  

Y. Ravindranath (USA)

8.30-8.50

Surgical approach in  Retinoblastoma

M. Naseripour (Iran)

8.50-9.10

Relapse strategy in  Retinoblastoma 

S. Epelman (Brazil)

9.10-9.30

 Bilateral Retinoblastoma

F. Ghasemi (Iran)

9.30-9.45

Cytogenetic in  Retinoblastoma

A. Ahani (Iran)

9.45-10.15

Panel Discussion

Y. Ravindranath(USA)
H. Shams(Iran)
S. Epelman(Brazil)
P. Vossough (Iran)

10:15 – 10.30

Break

Chair Persons: M. Molaian (Iran) - I. Sultan (Jordan) – A. Khaleghnejad (Iran) - P. Kurkure (India)

Time

Program

Time

Subject

Presenter

10:30 – 13:00

Wilm’s Tumor 

10.30-10.40

Current treatment in Wilm’s Tumor

P. Kurkure (India)

10.40-11.10

Partial nepherectomy in  Wilm’s Tumor 

M. Mollaian (Iran)

11.10-11.30

Preoperative Chemotherapy vs. Upfront Nepherectomy for Wilm's Tumor

I. Sultan (Jordan)

11.30-11.50

Role of XRT in  Wilm’s Tumor  

M. Ghalibafian (Iran)

11.50-12.10

Wilm's’ Tumor: A 10 Year Retrospective Study

A. Khaleghnejad (Iran) 

12.10-13.00

Panel Discussion

P. Kurkure (India)
M. Mollaian (Iran)
I. Sultan (Jordan)
M. Ghalibafian (Iran)
A. Khaleghnejad (Iran) 

13:00 – 14:00

Closing Remarks – SIOP Asia Board

Subject

Presenter

8:00 – 10:00

8.00-8.10

Survivors of Childhood Cancer Since 1982 (In 29 years)

M. Izadyar (Iran)

8.10-8.20

Outcome and prognostic factors seen in Pediatric Oncology patients admitted in Pediatric Intensive care unit in a developing country.

Z. Fadoo (Pakistan)

8.20-8.30

Cardio toxic effect of Anthracycline in Children with Acute Lymphoblastic Leukemia

F. Kompany (Iran)

8.30-8.40

Autologus Peripheral blood stem cell transplantation in lymphoma: experience in patient in partial remission

M. Mehdizadeh (Iran)

8.40-8.50

Pediatric Hematopoietic Stem cell transplantation ; Iranian experience

A. A. Hamidieh (Iran)

8.50-9.00

9.00-9.10

Primary Pediatric Orbital Implants after Enucleation for Retinoblastoma

S. Qureshi (India)

9.10-9.20

Excellent efficacy and tolerability of Imatinib Mesylate in pediatric chronic myeloid leukemia in a large cohort: Results from a tertiary care referral center in India.

B. Arora(India)

9.20-9.30

The Investigation of Pediatric Leukemia by immunophenotyping in IBTO (2007-2009)

M. Aghaeipour (Iran)

9.30-9.40

Study of Initial Results if Acute Lymphoblast Leucosis Treatment in Consolidation Period

ME.S. Babayev(Azerbaijan)

9.40-9.50

Anthracycline cardio toxicity in childhood malignancies

F. Moussavi (Iran)

9.50-10.00

Free paper

10:00 – 10:30

Break

Program

Subject

Presenter

10.30-12.00

Nursing Work Shop

Evaluation and Treatment of Chemotherapy Extravasation Injuries

AR. Farid Khomami (Iran)